Literature DB >> 23036776

Costs of allergic diseases from birth to two years in Finland.

S Alanne1, A Maskunitty, M Nermes, K Laitinen, M Pekurinen.   

Abstract

OBJECTIVES: Costing studies are needed to identify the resources used for treatment and inform payers of the costs incurred. The objectives were to determine the costs of diagnosing and treating atopic dermatitis, food allergy and asthma, and to compare the share of costs to society and to the family during the first two years of life. STUDY
DESIGN: The data were obtained from an ongoing mother-infant nutrition study. The sample comprised 60 infants who developed allergic disease by the age of 24 months and 56 healthy infants with no allergic disease.
METHODS: The costs included diagnosis and treatment of the allergy, disability allowances, travel expenses and time spent by parents.
RESULTS: The median costs per infant were €275 (range 94-1306) for atopic dermatitis, €1408 (163-5408) for asthma, €3182 (628-11195) for food allergy, and €10 (0-619) for the healthy infants due to the suspicion of allergic disease. The highest costs in atopic dermatitis were caused by primary care visits, topical treatments, travel costs and parents' time, and those for food allergy by hospital out-patient care, infant formulae for cow's milk allergy, disability allowances and travel costs. The families paid 43% of the costs arising from atopic dermatitis, 13.6% of those from food allergy and 16.5% of those from asthma.
CONCLUSIONS: Cow's milk allergy emerged as the most expensive allergic disease, especially for the society, and concurrent asthma in particular further increased the costs.
Copyright © 2012 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036776     DOI: 10.1016/j.puhe.2012.06.003

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

Review 1.  Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis.

Authors:  Jurgita Saulyte; Carlos Regueira; Agustín Montes-Martínez; Polyna Khudyakov; Bahi Takkouche
Journal:  PLoS Med       Date:  2014-03-11       Impact factor: 11.069

Review 2.  Understanding economic evidence for the prevention and treatment of atopic eczema.

Authors:  T H Sach; E McManus; N J Levell
Journal:  Br J Dermatol       Date:  2019-04-11       Impact factor: 9.302

3.  Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case-Control Study in Sweden.

Authors:  Gustaf Ortsäter; Kirk Geale; Alexander Rieem Dun; Joseph C Cappelleri; Amy Cha; William Romero; Dan Henrohn; Petra Neregard; Maureen P Neary
Journal:  Dermatol Ther (Heidelb)       Date:  2020-12-18

4.  Tolerogenic Effect Elicited by Protein Fraction Derived From Different Formulas for Dietary Treatment of Cow's Milk Allergy in Human Cells.

Authors:  Lorella Paparo; Gianluca Picariello; Cristina Bruno; Laura Pisapia; Valentina Canale; Antonietta Sarracino; Rita Nocerino; Laura Carucci; Linda Cosenza; Tommaso Cozzolino; Roberto Berni Canani
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

5.  Exploring low-income families' financial barriers to food allergy management and treatment.

Authors:  Leia M Minaker; Susan J Elliott; Ann Clarke
Journal:  J Allergy (Cairo)       Date:  2014-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.